| Treatment of metastatic colorectal cancer: ASCO guideline VK Morris, EB Kennedy, NN Baxter, AB Benson III, A Cercek, M Cho, ... Journal of Clinical Oncology 41 (3), 678-700, 2023 | 209 | 2023 |
| Validation of microsatellite instability detection using a comprehensive plasma-based genotyping panel J Willis, MI Lefterova, A Artyomenko, PM Kasi, Y Nakamura, K Mody, ... Clinical Cancer Research 25 (23), 7035-7045, 2019 | 204 | 2019 |
| Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3 JS Ross, M Fakih, SM Ali, JA Elvin, AB Schrock, J Suh, JA Vergilio, ... Cancer 124 (7), 1358-1373, 2018 | 199 | 2018 |
| Efficacy and safety of pembrolizumab in previously treated advanced neuroendocrine tumors: results from the phase II KEYNOTE-158 study J Strosberg, N Mizuno, T Doi, E Grande, JP Delord, R Shapira-Frommer, ... Clinical cancer research 26 (9), 2124-2130, 2020 | 185 | 2020 |
| Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and efficacy of AMG 510, a novel small molecule KRASG12C inhibitor, in advanced solid … M Fakih, B O'Neil, TJ Price, GS Falchook, J Desai, J Kuo, R Govindan, ... Journal of Clinical Oncology 37 (15_suppl), 3003-3003, 2019 | 179 | 2019 |
| Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines AB Benson, T Bekaii-Saab, E Chan, YJ Chen, MA Choti, HS Cooper, ... Journal of the National Comprehensive Cancer Network 11 (2), 141-152, 2013 | 174 | 2013 |
| Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer M Fakih, M Vincent Current Oncology 17 (Suppl 1), S18, 2010 | 171 | 2010 |
| CEA monitoring in colorectal cancer. What you should know. MG Fakih, A Padmanabhan Oncology (Williston Park, NY) 20 (6), 579-87; discussion 588, 594, 596 passim, 2006 | 159 | 2006 |
| Trifluridine–tipiracil and bevacizumab in refractory metastatic colorectal cancer GW Prager, J Taieb, M Fakih, F Ciardiello, E Van Cutsem, E Elez, ... New England Journal of Medicine 388 (18), 1657-1667, 2023 | 143 | 2023 |
| Cetuximab-induced hypomagnesemia in patients with colorectal cancer MG Fakih, G Wilding, J Lombardo Clinical colorectal cancer 6 (2), 152-156, 2006 | 143 | 2006 |
| Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab-or panitumumab-refractory … DL Reidy, E Vakiani, MG Fakih, MW Saif, JR Hecht, N Goodman-Davis, ... Journal of clinical oncology 28 (27), 4240-4246, 2010 | 141 | 2010 |
| Significance of signet-ring cells in patients with colorectal cancer R Pande, A Sunga, C LeVea, GE Wilding, W Bshara, M Reid, MG Fakih Diseases of the colon & rectum 51 (1), 50-55, 2008 | 141 | 2008 |
| Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines A Grothey, M Fakih, J Tabernero Annals of Oncology 32 (8), 959-967, 2021 | 136 | 2021 |
| Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial ME Reid, AJ Duffield‐Lillico, A Sunga, M Fakih, DS Alberts, JR Marshall International journal of cancer 118 (7), 1777-1781, 2006 | 133 | 2006 |
| Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity WW Ma, MW Saif, BF El‐Rayes, MG Fakih, TH Cartwright, JA Posey, ... Cancer 123 (2), 345-356, 2017 | 132 | 2017 |
| Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors GD Demetri, F De Braud, A Drilon, S Siena, MR Patel, BC Cho, SV Liu, ... Clinical Cancer Research 28 (7), 1302-1312, 2022 | 124 | 2022 |
| Association of tumour mutational burden with outcomes in patients with select advanced solid tumours treated with pembrolizumab in KEYNOTE-158 A Marabelle, MG Fakih, J Lopez, M Shah, R Shapira-Frommer, ... Annals of oncology 30, v477-v478, 2019 | 120 | 2019 |
| Localized colon cancer, version 3.2013 AB Benson, T Bekaii-Saab, E Chan, YJ Chen, MA Choti, HS Cooper, ... Journal of the National Comprehensive Cancer Network 11 (5), 519-528, 2013 | 116 | 2013 |
| Geriatric assessment-driven intervention (GAIN) on chemotherapy toxicity in older adults with cancer: A randomized controlled trial. D Li, CL Sun, H Kim, V Chung, M Koczywas, M Fakih, J Chao, L Chien, ... Journal of Clinical Oncology 38 (15_suppl), 12010-12010, 2020 | 108 | 2020 |
| A phase I/Ib trial of the VEGFR-sparing multikinase RET inhibitor RXDX-105 A Drilon, S Fu, MR Patel, M Fakih, D Wang, AJ Olszanski, D Morgensztern, ... Cancer discovery 9 (3), 384-395, 2019 | 106 | 2019 |
